Lilly to Acquire Sigilon for an Aggregate of Approximately $309M

Indianapolis and Cambridge, MA, June 29, 2023 (PRNewswire) -- Lilly and Sigilon Therapeutics announced that they have reached a definitive agreement for Lilly to acquire Sigilon. The collaboration aims to advance encapsulated cell therapies with the goal of providing long-term relief and improved care for patients living with diabetes.

Read full article here.